Breath Therapeutics completes venture financing

On March 8, respiratory disease company Breath Therapeutics Holding B.V. (Munich, Germany) raised €43.5 million ($46.2 million) in a series A round co-led by Gimv and Sofinnova Partners. Gilde Healthc...